高山企業(00616.HK)永義國際(01218.HK)附屬售380萬股建行(00939.HK) 料虧損448.4萬元
永義國際(01218.HK)與高山企業(00616.HK)聯合公布,間接全資附屬世昌及智聰分別於9月7日及9日在公開市場出售共380萬股建設銀行(00939.HK)股份,總代價約為1,805萬元,相當於每股出售股份平均價約4.75元。所得款項擬用作一般營運資金。
集團指,該等出售事項旨在平衡證券投資組合,預期將確認448.4萬元虧損。緊隨該等出售事項後,永義集團目前持有804.72萬股建設銀行股份,高山集團則不再持有任何建設銀行股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.